A rising number of reverse stock splits has prompted the Nasdaq stock exchange to rein in the practice by requiring more advanced shareholder notice.
Companies most often use a reverse stock split to raise the price of their shares in order to maintain their listing on the Nasdaq or New York Stock Exchange. Both exchanges can remove a company if the share price persistently trades below $1 — a problem several Minnesota companies have faced this year.
Bright Health Group, Foxo Technologies and Regis Corp. have all completed reverse stock splits in part to bring stock prices back into compliance.
The number of reverse splits has risen sharply around the country. In 2020, 94 companies announced reverse stock splits, which jumped to 196 in 2022 and to 164 halfway through 2023 — with more anticipated in the second half of the year.
In its notice to the Securities and Exchange Commission, Nasdaq stated that companies listed on its main exchange are mostly doing reverse splits to "to achieve compliance with Nasdaq's $1 bid price requirement."
Getting delisted from a major exchange can create compounding problems for a company. Some institutional investors may have rules against buying or even holding companies that are not on a major exchange. That greatly reduces the number of potential shareholders and the heights a stock price might reach.
Regis trades on the NYSE and has been trading under $1 since September. Regis announced a 1-for-20 reverse split on Nov. 17 that became effective on Nov. 29 to regain compliance with NYSE standards. On Wednesday the stock was trading about $9 per share, but the company is still out of compliance with other NYSE rules on market capitalization and stockholders' equity.
"The reverse stock split is primarily intended to bring the company into compliance with stock exchange minimum bid price requirements while we explore opportunities to remain listed on a national securities exchange," said Kersten Zupfer, chief financial officer of Regis Corp. "The reverse stock split is not expected to have a direct impact on the company's market capitalization deficiency."